Delivery Order SPE2DB22D3401-SPE2DB24FT4QN

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $16,723.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty medication, with a completion date of June 25, 2024. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $7,138.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $8,304.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract is for the delivery of ENBREL 50 MG/ML SYRINGE, a specialty medication, with an ultimate completion date of October 25, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,835.46 Firm Fixed Price Delivery Order covers the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division. This IDC serves as a primary vehicle for...
This federal contract award, valued at $8,304.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 50 MG/ML syringes. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for providing a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award, valued at $12,067.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty medication, to support military healthcare programs. The award is a delivery order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 50 MG/ML SYRINGEML. The contract has a ceiling value of $26,378.83 and is a firm fixed price Delivery Order with a completion date of January 15, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,520.89 Firm Fixed Price Delivery Order contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $20,226.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566627744 ENBREL 50 MG/ML SYRINGEML, a specialty medication, with a performance period extending through December 6, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $18,773.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4QN
    Delivery Order

This federal contract award, valued at $25,610.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 50 MG/ML syringes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a broad range of medical commodities to support military treatment programs and facilities worldwide. The award does not have a set-aside designation and is for a firm fixed-price delivery order, with a completion date of September 12, 2024. This contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries by ensuring the availability of critical pharmaceutical products.

Generated 12/11/24, 9:03 AM